Log In
Print this Print this

Aethoxysklerol, Asclera, polidocanol

  Manage Alerts
Collapse Summary General Information
Company Chemische Fabrik Kreussler & Co. GmbH
DescriptionInjectable sclerosing solution
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPeripheral vascular disease (PVD)
Indication DetailsTreat varicose veins
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today